ImageneBio, Inc. Balance Sheet
IMA|5 years of annual SEC 10-K data (FY2021-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 5 fiscal years. All figures from audited SEC 10-K filings.
ImageneBio, Inc. had $153M in total assets with negative shareholders' equity of $161M as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -0.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | $94.5M | $39.4M | $119.9M | $59.9M | $232.2M |
| Current Assets | $140.3M | $127.2M | $178.7M | $160.0M | $236.5M |
| PP&E (Net) | - | $593.0K | $2.3M | $3.2M | $2.4M |
| Total Assets | $153.0M | $141.5M | $192.1M | $172.3M | $247.9M |
| Current Liabilities | $11.2M | $10.8M | $14.2M | $21.5M | $27.2M |
| Shareholders' Equity | -$160.6M | $169.8M | $147.0M | $207.9M | -$101.0M |